Submission Details
| 510(k) Number | K000257 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 27, 2000 |
| Decision Date | February 23, 2000 |
| Days to Decision | 27 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K000257 is an FDA 510(k) clearance for the IMMULITE 2000 PAP, MODELS L2KPA2, L2KPA6, a Acid Phosphatase (prostatic), Tartrate Inhibited (Class II — Special Controls, product code JFH), submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on February 23, 2000, 27 days after receiving the submission on January 27, 2000. This device falls under the Immunology review panel. Regulated under 21 CFR 862.1020.
| 510(k) Number | K000257 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 27, 2000 |
| Decision Date | February 23, 2000 |
| Days to Decision | 27 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | JFH — Acid Phosphatase (prostatic), Tartrate Inhibited |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1020 |